P00520 (ABL1_MOUSE) Mus musculus (Mouse)

Tyrosine-protein kinase ABL1 UniProtKBInterProSTRINGInteractive Modelling

1123 aa; Sequence (Fasta) ; (Isoform 2; Isoform 3; Isoform 4)

Available Structures

24 Experimental Structures

DescriptionPDB IDOligo-stateRangeSeq id (%)Ligands
CRYSTAL STRUCTURE OF THE COMPLEX OF THE ABL TYROSINE KINASE SH3 DOMAIN WITH 3BP-1 SYNTHETIC PEPTIDE Heteromer
P55194;
64-121
100SO4;
Structure, thermodynamics, and the role of conformational dynamics in the interactions between the … Heteromer
Q64010;
757-765
100PEG;NA;
CRYSTAL STRUCTURE OF THE UNLIGANDED ABL TYROSINE KINASE SH3 DOMAINhomo-2-mer65-120
100
Structural basis for the auto-inhibition of c-Abl tyrosine kinasemonomer64-512
99.78MYR;P16;GOL;
Structural analysis of DFG-in and DFG-out dual Src-Abl inhibitors sharing a common vinyl purine tem…monomer229-514
100.0B90;
AP24534, a Pan-BCR-ABL Inhibitor for Chronic Myeloid Leukemia, Potently Inhibits the T315I Mutant a…monomer229-513
99.640LI;
Structural analysis of DFG-in and DFG-out dual Src-Abl inhibitors sharing a common vinyl purine tem…monomer229-511
100B91;
Crystal structure of ABL T315I mutant kinase domain bound with a DFG-out inhibitor AP24589monomer229-511
99.65XY3;
Crystal Structure of the T315I Mutant of Abl kinase bound with PPY-Amonomer229-511
99.64P3Y;
Crystal structure of ABL kinase domain bound with a DFG-out inhibitor AP24534monomer229-511
100.00LI;
Structure of Abl kinase in complex with imatinib and GNF-2monomer229-510
100.0STJ;STI;CL;
Structural basis for the auto-inhibition of c-Abl tyrosine kinasemonomer229-510
100CL;MYR;STI;
ABL1 IN COMPLEX WITH COMPOUND 7 AND IMATINIB (STI-571)monomer229-510
100.0GOL;CL;FYW;STI;
ABL1 IN COMPLEX WITH COMPOUND6 AND IMATINIB (STI-571)monomer229-510
100.0CL;FYH;STI;
Abl kinase domain in complex with NVP-AFG210monomer229-502
100.0KIN;
Crystal Structure of Abl kinase bound with PPY-Amonomer229-501
100.0P3Y;
CRYSTAL STRUCTURE OF ABL KINASE DOMAIN IN COMPLEX WITH A SMALL MOLECULE INHIBITORmonomer229-499
100PRC;
Crystal Structure of the c-Abl Kinase domain in complex with PD173955monomer232-502
100P17;
Crystal structure of mutant ABL kinase domain in complex with small molecule fragmentmonomer233-502
99.25SX7;
Crystal structure of mutant ABL kinase domain in complex with small molecule fragmentmonomer233-502
99.24SX7;
Crystal structure of mutant ABL kinase domain in complex with small molecule fragmentmonomer233-502
99.25SX7;
CRYSTAL STRUCTURE OF THE C-ABL KINASE DOMAIN IN COMPLEX WITH STI-571.monomer229-498
100CL;STI;
ABL kinase in complex with imatinib and a fragment (FRAG1) in the myristate pocketmonomer230-498
100.0STI;MS9;CL;
Abl kinase in complex with imatinib and fragment (FRAG2) in the myristate sitemonomer232-498
100.0STI;MS7;

3 SWISS-MODEL models

TemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
1opk.1.Amonomer0.8064-512
MYR;P16;99.80
1opl.2.Amonomer0.78121-499
P16;98.97
1zzp.1.Amonomer0.781017-1123
95.97

11 SWISS-MODEL models built on isoform sequence

IsoformTemplateOligo-stateQMEANDisCoRangeLigandsTrg-Tpl Seq id (%)
Isoform 21opk.1.Amonomer0.8158-505
MYR;P16;99.79
Isoform 21opl.2.Amonomer0.79115-493
P16;98.57
Isoform 21zzp.1.Amonomer0.781011-1117
95.97
Isoform 21y57.1.Amonomer0.7158-494
43.39
Isoform 31opk.1.Amonomer0.8159-507
MYR;P16;99.80
Isoform 31opl.2.Amonomer0.79116-494
P16;98.77
Isoform 31zzp.1.Amonomer0.781012-1118
95.97
Isoform 31y57.1.Amonomer0.7159-495
43.39
Isoform 41opl.1.Amonomer0.8181-531
MYR;P16;99.44
Isoform 41opl.2.Amonomer0.79140-518
P16;99.43
Isoform 41zzp.1.Amonomer0.781036-1142
95.97